What is the acceptable sample for coagulation testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acceptable Sample for Coagulation Testing

The correct answer is C: plasma collected using a 9:1 ratio of whole blood to 3.2% sodium citrate, which is the standardized and recommended sample collection method for accurate coagulation testing according to the International Society on Thrombosis and Haemostasis. 1

Why 3.2% Sodium Citrate is Preferred

The 3.2% sodium citrate concentration is specifically recommended over 3.8% sodium citrate for several important reasons:

  • It is less sensitive to underfilling effects, which can significantly alter test results 1, 2
  • Studies have shown that 3.2% sodium citrate allows for more reliable results even when tubes are not completely filled 2
  • The 9:1 ratio of whole blood to anticoagulant is critical for standardized testing 1, 3

Why Other Options Are Incorrect

  • Option A (10:1 ratio of whole blood to heparin): Heparin is an anticoagulant that interferes with coagulation testing by inhibiting thrombin and other coagulation factors, making it unsuitable for these tests 1

  • Option B (4:1 ratio of whole blood to EDTA): EDTA completely removes calcium from the sample, which prevents proper assessment of the coagulation cascade. Additionally, the ratio is incorrect for any coagulation testing 1

  • Option D (9:1 ratio of whole blood to 3.8% sodium citrate): While historically used, 3.8% sodium citrate is more sensitive to underfilling effects compared to 3.2% sodium citrate. Research has shown that with 3.8% citrate, statistically significant differences in PT results occur when tubes are less than 80% filled, whereas with 3.2% citrate, reliable results can be obtained with tubes filled to as low as 60% capacity for PT and 70% for aPTT 1, 2

Critical Sample Collection Parameters

For accurate coagulation testing, the following parameters must be observed:

  • Light-blue top tubes containing 3.2% sodium citrate must be used 1
  • The tube must maintain a precise 9:1 blood-to-anticoagulant ratio 1, 3
  • Tubes should be filled completely and gently inverted 3-4 times immediately after collection 1
  • Tubes should be filled to at least 90% of capacity to avoid falsely elevated results 1, 4

Processing Requirements

After collection, proper processing is essential:

  • Samples should be processed within 1 hour of collection 1, 3
  • Double centrifugation is recommended to ensure a residual platelet count of <10.0 × 10^9/L 1
  • Standard processing involves centrifuging samples at 2500 ×g for 15 minutes at room temperature 1
  • Alternative processing can include centrifugation at 3000g for 5 minutes, which has been shown to produce reliable results while reducing turnaround time 5

Common Pitfalls to Avoid

  • Underfilling tubes: This causes excess anticoagulant relative to blood volume, which spuriously prolongs coagulation times, especially aPTT 1, 4
  • Hemolysis: Even moderate blood cell lysis (as low as 0.9%) can significantly influence the reliability of coagulation test results 6
  • Improper mixing: Inadequate mixing can lead to partial clotting and inaccurate results 1
  • Using butterfly needles without discarding the first tube: The air volume in butterfly tubing can affect the blood-to-anticoagulant ratio 1

References

Guideline

Coagulation Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Samples in Coagulation Test].

Rinsho byori. The Japanese journal of clinical pathology, 2015

Research

Quality standards for sample collection in coagulation testing.

Seminars in thrombosis and hemostasis, 2012

Research

Five-minute preparation of platelet-poor plasma for routine coagulation testing.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2010

Research

Interference of blood cell lysis on routine coagulation testing.

Archives of pathology & laboratory medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.